TREATMENT OF PARKINSONISM - BROMOCRIPTINE, CARBIDOPA-LEVODOPA, AND LEVODOPA COMPARED IN A DOUBLE-BLIND-STUDY

被引：0
|
作者：
KARTZINEL, R
PERLOW, M
TEYCHENNE, PF
GIELEN, AC
GILLESPIE, MM
CALNE, DB
机构：
来源：
NEUROLOGY | 1976年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [1] BROMOCRIPTINE AND LEVODOPA (WITH OR WITHOUT CARBIDOPA) IN PARKINSONISM
    KARTZINEL, R
    TEYCHENNE, P
    GILLESPIE, MM
    PERLOW, M
    GIELEN, AC
    SADOWSKY, DA
    CALNE, DB
    LANCET, 1976, 2 (7980): : 272 - 275
  • [2] CARBIDOPA-LEVODOPA COMBINATION IN TREATMENT OF PARKINSON DISEASE
    BOUNDS, JA
    HUNT, GM
    WESTERN JOURNAL OF MEDICINE, 1977, 127 (02): : 135 - 136
  • [3] PSYCHIATRIC-SYMPTOMS WITH INITIATION OF CARBIDOPA-LEVODOPA TREATMENT
    LIN, JTY
    ZIEGLER, DK
    NEUROLOGY, 1976, 26 (07) : 699 - 700
  • [4] HUMAN TRANSPLACENTAL TRANSFER OF CARBIDOPA-LEVODOPA
    MERCHANT, CA
    COHEN, G
    MYTILINEOU, C
    DIROCCO, A
    MOROS, D
    MOLINARI, S
    YAHR, MD
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1995, 9 (2-3) : 239 - 242
  • [5] Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
    Hauser, Robert A.
    Hsu, Ann
    Kell, Sherron
    Espay, Alberto J.
    Sethi, Kapil
    Stacy, Mark
    Ondo, William
    O'Connell, Martin
    Gupta, Suneel
    LANCET NEUROLOGY, 2013, 12 (04): : 346 - 356
  • [6] Effect of levodopa treatment for parkinsonism in welders - A double-blind study
    Koller, WC
    Lyons, KE
    Truly, W
    NEUROLOGY, 2004, 62 (05) : 730 - 733
  • [7] EARLY COMBINATION OF BROMOCRIPTINE WITH LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE - A 5-YEAR DOUBLE-BLIND-STUDY
    MOORE, AP
    BAKHEIT, M
    HENDERSON, L
    THOMAS, M
    ANNALS OF NEUROLOGY, 1994, 36 (02) : 281 - 281
  • [8] STANDARD CARBIDOPA-LEVODOPA VERSUS CONTROLLED-RELEASE CARBIDOPA-LEVODOPA IN PARKINSONS-DISEASE - A POSTMARKET ANALYSIS
    MANYAM, BV
    SHONKWILER, S
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 (02) : 128 - 137
  • [9] Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet®), sustained-release carbidopa-levodopa (Sinemet® CR), and carbidopa-levodopa-entacapone (Stalevo®)
    Hsu, Ann
    Yao, Hsuan-Ming
    Gupta, Suneel
    Modi, Nishit B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (09): : 995 - 1003
  • [10] PSYCHOSIS IN PATIENT ON BROMOCRIPTINE AND LEVODOPA WITH CARBIDOPA
    LIPPER, S
    LANCET, 1976, 2 (7985): : 571 - 572
12345